Literature DB >> 16712695

Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2.

A M Hever1, K A Williamson, V van Heyningen.   

Abstract

Eye development initiates as an evagination of the early neural plate, before the closure of the neural tube. Structural malformations of the eye such as anophthalmia and microphthalmia arise very early in development. It is not surprising therefore that three of the genes currently identified to play a significant role in these developmental eye anomalies are also major players in brain development and regionalization. However, as has been emerging for a high proportion of transcriptional regulators studied, these genes have evolved to play multiple roles throughout development, and perhaps even in adult tissue maintenance. This complex spatiotemporal expression pattern requires elaborate regulatory systems which we are beginning to unravel. A major component of these complex regulatory networks is a series of cis-acting elements, highly conserved through evolution, which spread large distances from the coding region of each gene. We describe how cross regulation for PAX6, SOX2 and perhaps OTX2 has now been uncovered, pointing to the mechanisms that can fine-tune the expression of such essential developmental components. These interactions also help us understand why there is significant phenotypic overlap between mutations at these three loci.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712695     DOI: 10.1111/j.1399-0004.2006.00619.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  62 in total

Review 1.  Eye development genes and known syndromes.

Authors:  Anne M Slavotinek
Journal:  Mol Genet Metab       Date:  2011-09-29       Impact factor: 4.797

2.  Stage-dependent modes of Pax6-Sox2 epistasis regulate lens development and eye morphogenesis.

Authors:  April N Smith; Leigh-Anne Miller; Glenn Radice; Ruth Ashery-Padan; Richard A Lang
Journal:  Development       Date:  2009-09       Impact factor: 6.868

3.  A [c.566-2A>G] heterozygous mutation in the PAX6 gene causes aniridia with mild visual impairment.

Authors:  F Beby; K Dieterich; P Calvas
Journal:  Eye (Lond)       Date:  2011-01-28       Impact factor: 3.775

4.  The Cone Photoreceptor Mosaic in Aniridia: Within-Family Phenotype-Genotype Discordance.

Authors:  Hilde R Pedersen; Maureen Neitz; Stuart J Gilson; Erlend C S Landsend; Øygunn Aas Utheim; Tor Paaske Utheim; Rigmor C Baraas
Journal:  Ophthalmol Retina       Date:  2019-02-05

Review 5.  Conserved genetic pathways associated with microphthalmia, anophthalmia, and coloboma.

Authors:  Linda M Reis; Elena V Semina
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-03

6.  Implication of non-coding PAX6 mutations in aniridia.

Authors:  Julie Plaisancié; M Tarilonte; P Ramos; C Jeanton-Scaramouche; V Gaston; H Dollfus; D Aguilera; J Kaplan; L Fares-Taie; F Blanco-Kelly; C Villaverde; C Francannet; A Goldenberg; I Arroyo; J M Rozet; C Ayuso; N Chassaing; P Calvas; M Corton
Journal:  Hum Genet       Date:  2018-10-05       Impact factor: 4.132

7.  Molecular links among the causative genes for ocular malformation: Otx2 and Sox2 coregulate Rax expression.

Authors:  Hiroki Danno; Tatsuo Michiue; Keisuke Hitachi; Akira Yukita; Shoichi Ishiura; Makoto Asashima
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

8.  A novel PAX6 mutation in a large Chinese family with aniridia and congenital cataract.

Authors:  Fucheng Cai; Jianfang Zhu; Wen Chen; Tie Ke; Fang Wang; Xin Tu; Ying Zhang; Runming Jin; Xiaoyan Wu
Journal:  Mol Vis       Date:  2010-06-22       Impact factor: 2.367

9.  Transcriptional features of genomic regulatory blocks.

Authors:  Altuna Akalin; David Fredman; Erik Arner; Xianjun Dong; Jan Christian Bryne; Harukazu Suzuki; Carsten O Daub; Yoshihide Hayashizaki; Boris Lenhard
Journal:  Genome Biol       Date:  2009-04-19       Impact factor: 13.583

10.  A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction.

Authors:  Robert H Henderson; Kathleen A Williamson; Joanna S Kennedy; Andrew R Webster; Graham E Holder; Anthony G Robson; David R FitzPatrick; Veronica van Heyningen; Anthony T Moore
Journal:  Mol Vis       Date:  2009-11-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.